Sanna Pasonen-Seppänen
Vanhempi yliopistonlehtori
Biolääketieteen yksikkö, Lääketieteen laitos, Terveystieteiden tiedekunta
sanna.pasonen@uef.fi | 040 355 2030
Julkaisut
71/71 kappaletta-
Differential expression analysis identifies a prognostically significant extracellular matrix–enriched gene signature in hyaluronan-positive clear cell renal cell carcinoma
Jokelainen, Otto; Rintala, Teemu J; Fortino, Vittorio; Pasonen-Seppänen, Sanna; Sironen, Reijo; Nykopp, Timo K. 2024. Scientific reports. 14: -
Oncogenic KEAP1 mutations activate TRAF2-NFκB signaling to prevent apoptosis in lung cancer cells
Deen, Ashik Jawahar; Adinolfi, Simone; Härkönen, Jouni; Patinen, Tommi; Liu, Xiaonan; Laitinen, Tuomo; Takabe, Piia; Kainulainen, Kirsi; Pasonen-Seppänen, Sanna; Gawriyski, Lisa M; Arasu, Uma Thanigai; Selvarajan, Ilakya; Mäkinen, Petri; Laitinen, Hanna; Kansanen, Emilia; Kaikkonen, Minna U; Poso, Antti; Varjosalo, Markku; Levonen, Anna-Liisa. 2024. Redox biology. 69: -
Translatome profiling reveals Itih4 as a novel smooth muscle cell–specific gene in atherosclerosis
Ravindran, Aarthi; Holappa, Lari; Niskanen, Henri; Skovorodkin, Ilya; Kaisto, Susanna; Beter, Mustafa; Kiema, Miika; Selvarajan, Ilakya; Nurminen, Valtteri; Aavik, Einari; Aherrahrou, Rédouane; Pasonen-Seppänen, Sanna; Fortino, Vittorio; Laakkonen, Johanna P; Ylä-Herttuala, Seppo; Vainio, Seppo; Örd, Tiit; Kaikkonen, Minna U. 2024. Cardiovascular research. 120: 869-882 -
A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors
Tiainen, Satu; Nurmela, Veera; Selander, Tuomas; Turunen, Patrik; Pasonen-Seppänen, Sanna; Kettunen, Tiia; Kuittinen, Outi; Auvinen, Päivi; Rönkä, Aino. 2023. Bmc cancer. 23: . 1186 -
Irradiation Alters the Expression of MUC1, CD44 and Hyaluronan in Oral Mucosal Epithelium
Kashyap, Bina; Naumanen, Konsta; Mikkonen, Jopi; Dekker, Hannah; Schulten, Engelbert; Bloemena, Elisabeth; Pasonen-Seppänen, Sanna; Kullaa, Arja. 2022. Biomedicines. 10: -
M1 Macrophages Induce Protumor Inflammation in Melanoma Cells through TNFR–NF-κB Signaling
Kainulainen, Kirsi; Takabe, Piia; Heikkinen, Sami; Aaltonen, Niina; de la Motte, Carol; Rauhala, Leena; Durst, Franziska C; Oikari, Sanna; Hukkanen, Taija; Rahunen, Eija; Ikonen, Ella; Hartikainen, Jaana M; Ketola, Kirsi; Pasonen-Seppänen, Sanna. 2022. Journal of investigative dermatology. 1412: 3041-3051.e10 -
The Association of CD8+ Cytotoxic T Cells and Granzyme B+ Lymphocytes with Immunosuppressive Factors, Tumor Stage and Prognosis in Cutaneous Melanoma
Salmi, Satu; Hälinen, Kaisla; Lin, Anton; Suikkanen, Sanna; Jokelainen, Otto; Rahunen, Eija; Siiskonen, Hanna; Pasonen-Seppänen, Sanna. 2022. Biomedicines. 10: -
The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma
Takabe, Piia; Siiskonen, Hanna; Rönkä, Aino; Kainulainen, Kirsi; Pasonen-Seppänen, Sanna. 2022. Frontiers in oncology. 11: -
The calcium-activated chloride channel-associated protein rCLCA2 is expressed throughout rat epidermis, facilitates apoptosis and is downmodulated by UVB
Hämäläinen, L; Bart, G; Takabe, P; Rauhala, L; Deen, A; Pasonen-Seppänen, S; Kärkkäinen, E; Kärnä, R; Kumlin, T; Tammi, M; I; Tammi, RH. 2021. Histochemistry and cell biology. 5: 605-615 -
The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study
Salmi, Satu; Lin, Anton; Hirschovits-Gerz, Benjamin; Valkonen, Mari; Aaltonen, Niina; Sironen, Reijo; Siiskonen, Hanna; Pasonen-Seppänen, Sanna. 2021. Bmc cancer. 21: 641